SCHEMBL29180821

SCHEMBL29180821

COc1cc(CC(=O)N(C)C)ccc1NC(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 1/20 0.42
▸ MTNR1B P49286 1/20 0.42
▸ KCNQ4 P56696 3/20 0.41
▸ KCNQ5 Q9NR82 3/20 0.41
▸ GAA P10253 2/20 0.40
▸ MMP1 P03956 1/20 0.40
▸ MMP2 P08253 1/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ MMP8 P22894 1/20 0.40
▸ MMP13 P45452 1/20 0.40
▸ ABL1 P00519 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ PIK3CD O00329 1/20 0.40
▸ EGFR P00533 1/20 0.40
▸ KDR P35968 1/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ PIK3CG P48736 1/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ PRKDC P78527 1/20 0.40
▸ PI4KB Q9UBF8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24803691 0.90 MMP1 (0.46) MTNR1AMTNR1BKCNQ4KCNQ5GAA
SCHEMBL6587449 0.86 GAA (0.54) MTNR1AMTNR1BGAAABL1ALDH1A1
SCHEMBL12044500 0.83 HTT (0.47) MTNR1AMTNR1BKCNQ4KCNQ5GAA
SCHEMBL15752675 0.83 PYGL (0.48) MTNR1AMTNR1BKCNQ4KCNQ5GAA
SCHEMBL7968884 0.82 HTT (0.41) MTNR1AMTNR1BGAAABL1ALDH1A1
SCHEMBL19961013 0.81 KCNQ4 (0.42) MTNR1AMTNR1BKCNQ4KCNQ5GAA
SCHEMBL29180880 0.81 KCNQ4 (0.42) MTNR1AMTNR1BKCNQ4KCNQ5GAA
SCHEMBL30148584 0.80 GAA (0.44) GAAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL20080089 0.79 PPARG (0.48) ALDH1A1MEN1KMT2AHTTMAPT
SCHEMBL19966996 0.79 MAPT (0.44) MTNR1AMTNR1BKCNQ4KCNQ5GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117580836-A Pyrimidine ring structure derivative and application thereof 四川汇宇制药股份有限公司 2024-02-20 — — CN disclosed
Send feedback